ATAZANAVIR

Trials studying ATAZANAVIR

• phase2Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvadacompletedn=35
• —Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartumcompletedn=205
• phase4Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIVterminatedn=11
• phase3A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)completedn=499
• phase2A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremiacompletedn=10
• phase3Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppressioncompletedn=117
• phase3Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TCterminatedn=3
• phase3Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbonewithdrawn